デフォルト表紙
市場調査レポート
商品コード
1362987

臨床試験患者募集サービスの市場規模、シェア、動向分析レポート:サービスタイプ別、フェーズ別、治療領域別、年齢層別、地域別、セグメント予測、2023年~2030年

Clinical Trial Patient Recruitment Services Market Size, Share & Trends Analysis Report By Service Type, By Phase, By Therapeutic Area, By Age group, By Region, And Segment Forecasts, 2023 - 2030


出版日
ページ情報
英文 149 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
臨床試験患者募集サービスの市場規模、シェア、動向分析レポート:サービスタイプ別、フェーズ別、治療領域別、年齢層別、地域別、セグメント予測、2023年~2030年
出版日: 2023年09月12日
発行: Grand View Research
ページ情報: 英文 149 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床試験患者募集サービス市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界の臨床試験患者募集サービス市場規模は2030年までに15億6,000万米ドルに達し、2023年から2030年までのCAGRは8.07%になると予測されています。

製薬・医療分野の成長、臨床試験需要の増加、分散型臨床試験の採用は、臨床試験患者募集サービス市場の成長を支える要因の一部です。

しかし、COVID-19の大流行は世界市場に影響を及ぼしており、COVID-19の発生により、世界中の臨床試験が自主的に一時停止されています。一時的なロックダウンは臨床試験、特に患者募集業界に大きな混乱をもたらしました。ロックダウンは患者の治験施設への訪問を制限し、最終的にいくつかの臨床試験から患者集団の大幅な脱落につながっています。

しかし、業界全体で事業を展開する企業は、M&A、臨床試験の分散化、患者の遠隔モニタリングなどのデジタル技術の導入などの対策を採用することで、パンデミックの悪影響を軽減することに注力してきました。このような要因により、2021年以降、業界は通常の成長率に戻ることができました。

製薬企業は、ヘルスケアの専門知識の世界で競争力と柔軟性を維持するため、研究開発活動に徐々に注力しています。企業は、基礎研究から患者登録サービスまで、幅広い業務のアウトソーシングに注力しています。デジタルコミュニケーションは、患者募集サービス市場全体で見られる最近の動向のひとつです。

オンラインプラットフォームの助けを借りて、リクルートの成長は合理化されているようです。臨床試験については、従来の印刷物やテレビ・ラジオによるアウトリーチと比較して、オンライン・ソースを通じて知る人が大多数です。そのため、ソーシャルメディア、ウェブリスニング、オンラインスクリーナーなど、いくつかのe-リクルートメント戦術が進化しています。

さらに、モバイル機器の利用が増えるにつれ、スマートフォンのアプリケーションやテキストメッセージの利用も広まっています。例えば北米では、臨床研究の約11%にソーシャルメディア・コミュニケーションが関与しています。したがって、前述の要因は市場の成長をサポートすると予想されます。

臨床試験患者募集サービス市場のレポートハイライト

  • 第III相試験はコストが高いため、第III相試験が2022年の売上高シェア57.2%以上で市場を独占。
  • 患者募集・登録サービス分野は、患者登録サービスにおけるデジタル技術の採用増加により、予測期間中に8.3%の有利な成長が見込まれます。
  • 治療分野別では、疼痛と麻酔が2021年に13.7%と最も高い市場シェアを占めました。これは、疼痛管理に関連する費用が他の治療分野よりも大幅に高いため、同時に患者募集・維持サービスの費用が増加するためです。
  • 年齢層別では、成人(18~64歳)セグメントが予測期間中にかなりの成長率を示すと予想されるが、これはこの年齢層における健康状態の有病率の増加によるものです。
  • 北米は2022年に50.1%の最大シェアを占めました。同地域では多くの臨床試験が進行中であることから、同市場は大幅な成長が見込まれています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 臨床試験患者募集サービス市場:変数、動向、範囲

  • 市場系統の見通し
  • 臨床試験患者募集サービスのダイナミクス
  • 市場力学
  • 患者採用管理の動向
  • ポーターのファイブフォース分析
  • PEST分析
  • COVID-19症による臨床試験患者募集サービス市場への影響

第4章 臨床試験患者募集サービス市場:サービスタイプセグメントの推定・動向分析

  • サービスタイプセグメント別の臨床試験患者募集サービス市場:重要なポイント
  • サービスタイプ別
  • 定義と範囲
  • サービス別市場シェア分析、2022年および2030年

第5章 臨床試験患者募集サービス市場:段階セグメントの推定・動向分析

  • フェーズセグメント別の臨床試験患者募集サービス市場:重要なポイント
  • フェーズ別
  • 定義と範囲
  • 臨床試験患者募集フェーズ:フェーズ市場シェア分析、2022年および2030年

第6章 臨床試験患者募集サービス市場:治療領域推定・動向分析

  • 治療領域セグメント別の臨床試験患者募集サービス市場:重要なポイント
  • 治療領域別
  • 定義と範囲
  • 臨床試験患者募集サービス:市場シェア分析、2022年および2030年

第7章 臨床試験患者募集サービス市場:年齢層推定・動向分析

  • 臨床試験患者募集サービス市場の年齢層別セグメント:重要なポイント
  • 年齢層別
  • 定義と範囲
  • 臨床試験患者募集サービス:市場シェア分析、2022年および2030年

第8章 地域推定・動向分析、2018~2030年

  • 地域別の展望
  • 地域市場シェア分析、2022年および2030年
  • 地域のマーケットプレース、重要なポイント
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • 韓国
    • タイ
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第9章 競合情勢

  • 企業の分類
  • 市場参入企業の概説
  • 財務実績
  • サービスのベンチマーク
    • マーケットリーダー
  • 戦略マッピング
    • サービス開始/アップグレード
    • 合併/買収/合弁事業
    • パートナーシップ契約
    • 拡大
    • その他

第10章 重要なポイント

図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Impact of COVID-19 on new patients entering trials
  • Table 4 Impact of COVID-19 on other therapeutic areas
  • Table 5 Clinical Trial Patient Recruitment Services Market revenue estimates and forecast, by service type, 2018 - 2030 (USD Million)
  • Table 6 Clinical trial patient recruitment services market revenue estimates and forecast, by phase, 2018 - 2030 (USD Million)
  • Table 7 Clinical trial patient recruitment services market revenue estimates and forecast, by therapeutic areas, 2018 - 2030 (USD Million)
  • Table 8 Medicines in development for neurological disorders (mental illness) 2023
  • Table 9 Clinical trial patient recruitment services market revenue estimates and forecast, by age group, 2018 - 2030 (USD Million)
  • Table 10 Participants' overview
  • Table 11 Financial performance
  • Table 12 Company profiles: Service benchmarking
  • Table 13 Key company initiating service launches/upgrades
  • Table 14 Key companies initiating mergers/acquisitions/joint ventures
  • Table 15 Key companies initiating partnerships.
  • Table 16 Key Companies Initiating Expansion
  • Table 17 Key companies initiating others

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Segment snapshot
  • Fig. 9 Clinical trial patient recruitment services market segmentation
  • Fig. 10 Parent market outlook (USD Billion)
  • Fig. 11 Related/ancillary market outlook (USD Billion)
  • Fig. 12 Clinical trial patient recruitment services market dynamics
  • Fig. 13 Pharmaceutical R&D spending, 2018 - 2028 (USD Billion)
  • Fig. 14 Patient retention and Recruitment key parameters
  • Fig. 15 Patient recruitment tactics
  • Fig. 16 Usage of digital tools for patient-related clinical trial services
  • Fig. 17 Porter's Five Forces analysis
  • Fig. 18 Political, social, economic, and technological analysis
  • Fig. 19 Companies with affected trials, by size
  • Fig. 20 Affected trials, by study phase
  • Fig. 21 Clinical trial patient recruitment services market service type outlook: Segment dashboard
  • Fig. 22 Clinical trial patient recruitment services: Services movement analysis
  • Fig. 23 Patient recruitment & registry services market, 2018 - 2030 (USD Million)
  • Fig. 24 Patient retention market, 2018 - 2030 (USD Million)
  • Fig. 25 Others market, 2018 - 2030 (USD Million)
  • Fig. 26 Clinical trial patient recruitment services market phase outlook: Segment dashboard
  • Fig. 27 Clinical trial patient recruitment services market: Phase movement analysis
  • Fig. 28 Phase I market, 2018 - 2030 (USD Million)
  • Fig. 29 Phase II market, 2018 - 2030 (USD Million)
  • Fig. 30 Phase III market, 2018 - 2030 (USD Million)
  • Fig. 31 Phase IV market, 2018 - 2030 (USD Million)
  • Fig. 32 Clinical trial patient recruitment services market therapeutic areas outlook: Segment dashboard
  • Fig. 33 Clinical trial patient recruitment services market: Therapeutic area movement analysis
  • Fig. 34 Pain and Anesthesia market, 2018 - 2030 (USD Million)
  • Fig. 35 Oncology market, 2018 - 2030 (USD Million)
  • Fig. 36 Central nervous system market, 2018 - 2030 (USD Million)
  • Fig. 37 Cardiovascular market, 2018 - 2030 (USD Million)
  • Fig. 38 Respiratory market, 2018 - 2030 (USD Million)
  • Fig. 39 Endocrine market, 2018 - 2030 (USD Million)
  • Fig. 40 Anti-Infective market, 2018 - 2030 (USD Million)
  • Fig. 41 Autoimmune clinical trial by phase, 2020 (%)
  • Fig. 42 Others market, 2018 - 2030 (USD Million)
  • Fig. 43 Clinical trial patient recruitment services market age group pe outlook: Segment dashboard
  • Fig. 44 Clinical trial patient recruitment services: Age group movement analysis
  • Fig. 45 Child market, 2018 - 2030 (USD Million)
  • Fig. 46 Adults market, 2018 - 2030 (USD Million)
  • Fig. 47 Older adults' market, 2018 - 2030 (USD Million)
  • Fig. 48 Clinical trial patient recruitment services market revenue, by region, 2022 & 2030 (USD Million)
  • Fig. 49 Regional market share analysis, 2022 & 2030
  • Fig. 50 Regional marketplace: Key takeaways
  • Fig. 51 Regional marketplace: Key takeaways
  • Fig. 52 North America: Regulatory framework
  • Fig. 53 North America clinical trial patient Recruitment Services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 U.S. clinical trial patient recruitment services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Canada clinical trial patient recruitment Services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Europe: Regulatory framework
  • Fig. 59 Europe clinical trial patient recruitment services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Germany clinical trial patient recruitment services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 UK clinical trial patient recruitment Services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 France clinical trial patient recruitment services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Spain clinical trial patient recruitment services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Italy clinical trial patient recruitment services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Denmark clinical trial patient recruitment services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Sweden clinical trial patient recruitment services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Norway clinical trial patient Recruitment Services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Asia Pacific: Regulatory framework
  • Fig. 77 Asia Pacific clinical trial patient recruitment services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key Country Dynamics
  • Fig. 79 Japan clinical trial patient recruitment Services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key Country Dynamics
  • Fig. 81 China clinical trial Patient Recruitment Services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key Country Dynamics
  • Fig. 83 India clinical trial patient recruitment services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key Country Dynamics
  • Fig. 85 South Korea clinical trial patient recruitment Services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamic
  • Fig. 87 Thailand clinical trial patient recruitment services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamic
  • Fig. 89 Australia clinical trial patient recruitment Services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Latin America: Regulatory framework
  • Fig. 91 Latin America clinical trial patient recruitment services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Brazil clinical trial patient recruitment services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Mexico clinical trial patient recruitment services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Argentina clinical trial patient recruitment services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 MEA: Regulatory framework
  • Fig. 99 MEA clinical trial patient recruitment services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 South Africa clinical trial patient recruitment services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 Saudi Arabia clinical trial patient recruitment services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 104 Key country dynamics
  • Fig. 105 UAE Clinical trial patient recruitment services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 106 Key country dynamics
  • Fig. 107 Kuwait clinical trial patient recruitment services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 108 Key company categorization
  • Fig. 109 Company market position analysis
  • Fig. 110 Strategic Framework
目次
Product Code: GVR-4-68039-922-3

Clinical Trial Patient Recruitment Services Market Growth & Trends:

The global clinical trial patient recruitment services market size is expected to reach USD 1.56 billion by 2030 witnessing a CAGR of 8.07% from 2023 to 2030, according to a new report by Grand View Research, Inc..

The growing pharmaceutical and medical sectors, increasing demand for clinical studies, and adoption of decentralized clinical trials are a few of the factors supporting the growth of the clinical trial patient recruitment services market.

However, the COVID-19 pandemic has affected the global market, the outbreak of COVID-19 has caused a voluntary pause in the clinical trials across the globe. The temporary lockdown has significantly disrupted clinical trials, especially in the patient recruitment industry. The lockdown has restricted the patient's visits to trial sites, which has ultimately led to significant dropouts of the patient population from several clinical trials.

However, companies operating across the industry have focused on mitigating the negative impact of the pandemic by adopting measures such as mergers and acquisitions, implementation of digital technologies such as decentralized clinical trials, remote monitoring of patients, and a few others. Such factors helped the industry to flourish back to its normal growth rate post-2021.

Pharmaceutical organizations are progressively focusing on R&D activities to remain competitive & flexible in the world of healthcare expertise. Companies are focusing on outsourcing tasks ranging from basic research to patient enrollment services. Digital methods of communication are one of the most recent trends witnessed across the patient recruitment services market.

With the help of online platforms, the recruitment growth seems to be streamlining. The majority of people learn about clinical trials through online sources compared to traditional print or TV/radio outreach. Hence, several e-recruitment tactics are evolving, such as social media, web listening, as well as online screeners.

In addition, with the increasing usage of mobile devices, the use of smartphone applications and text messaging has become more widespread. For instance, in North America, about 11% of clinical studies involve social media communications. Hence, the aforementioned factors are anticipated to support the growth of the market.

Clinical Trial Patient Recruitment Services Market Report Highlights:

  • The phase III segment dominated the market with a revenue share of more than 57.2% in 2022 due to the high cost associated with phase III studies
  • The patient recruitment & registry services segment is anticipated to witness lucrative growth of 8.3% during the forecast period owing to the increasing adoption of digital technologies in patient enrolment services
  • Pain and Anesthesia in terms of therapeutic areas held the highest market share of 13.7% in 2021. This is because the cost related to pain management is significantly higher than in other therapeutic areas, thus simultaneously increasing the fees for patient recruitment and retention services
  • In terms of age group, the adult (18 - 64 Years) segment is expected to witness a considerable growth rate across the forecast timeframe, owing to the increasing prevalence of health conditions in the age group
  • North America held the largest share of 50.1% in 2022. The market is expected to grow significantly, driven by the region's substantial number of ongoing clinical trials.

Table Of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Report Scope
    • 1.1.2 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
  • 1.7 List Of Secondary Sources
  • 1.8 List Of Primary Sources
  • 1.9 List Of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective - 1:
    • 1.10.2 Objective - 2:
    • 1.10.3 Objective - 3:
    • 1.10.4 Objective - 4:

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot
  • 2.4 Segment Outlook

Chapter 3 Clinical Trial Patient Recruitment Services Market: Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Clinical Trial Patient Recruitment Services Dynamics
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
      • 3.3.1.1 High R&D Spending Of Pharmaceutical Companies
      • 3.3.1.2 Increase In Number Of Global Clinical Trials
      • 3.3.1.3 Adoption Of Digital Clinical Trials
      • 3.3.1.4 Increase In Offshoring Of Clinical Trials In Emerging Market
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Lack Of Awareness Towards Clinical Trials
  • 3.4 Patient Recruitment Management Trends
    • 3.3.1 Patient Recruitment Tactics
  • 3.5 Porter's Five Forces Analysis
  • 3.6 Pest Analysis
  • 3.7 Covid-19 Impact On Clinical Trial Patient Recruitment Services Market
    • 3.7.1 Disrupted Clinical Trials:
    • 3.7.2 Obstacles In Clinical Trials:
    • 3.7.3 Covid-19 Impact On Key Market Players
      • 3.7.3.1 IQVIA
      • 3.7.3.2 ICON PLC
      • 3.7.3.3 PPD (Thermo Fisher Scientific Inc.)
      • 3.7.3.4 CHARLES RIVER Laboratories
    • 3.7.4 Post-Covid-19 Impact On The Market

Chapter 4 Clinical Trial Patient Recruitment Services Market: Service Type Segment Estimates & Trend Analysis

  • 4.1 Clinical Trial Patient Recruitment Services Market By Service Type Segment: Key Takeaways
  • 4.2 Clinical Trial Patient Recruitment Services Market Estimates & Forecast, By Service Type (USD Million)
  • 4.3 Definitions & Scope
  • 4.4 By Services Market Share Analysis, 2022 & 2030
    • 4.4.1 Patient Recruitment & Registry Services
      • 4.4.1.1 Patient Recruitment & Registry Services Market, 2018 - 2030 (USD Million)
    • 4.4.2 Patient Retention Market, 2018 - 2030 (USD Million)
      • 4.4.2.1 Patient Retention Market, 2018 - 2030 (USD Million)
    • 4.4.3 Others
      • 4.4.3.1 Others Market, 2018 - 2030 (USD Million)

Chapter 5 Clinical Trial Patient Recruitment Services Market: Phase Segment Estimates & Trend Analysis

  • 5.1 Clinical Trial Patient Recruitment Services Market By Phase Segment: Key Takeaways
  • 5.2 Clinical Trial Patient Recruitment Services Market Estimates & Forecast, By Phase (USD Million)
  • 5.3 Clinical Trial Patient Recruitment Services Market: Definition & Scope
  • 5.4 Clinical Trial Patient Recruitment Phase: Phase Market Share Analysis, 2022 & 2030
    • 5.4.1 Phase I
      • 5.4.1.1 Phase I Market, 2018 - 2030 (USD Million)
    • 5.4.2 Phase Ii
      • 5.4.2.1 Phase Ii Market, 2018 - 2030 (USD Million)
    • 5.4.3 Phase Iii
      • 5.4.3.1 Phase Iii Market, 2018 - 2030 (USD Million)
    • 5.4.4 Phase Iv
      • 5.4.4.1 Phase Iv Market, 2018 - 2030 (USD Million)

Chapter 6 Clinical Trial Patient Recruitment Services Market: Therapeutic Areas Segment Estimates & Trend Analysis

  • 6.1 Clinical Trial Patient Recruitment Services Market By Therapeutic Areas Segment: Key Takeaways
  • 6.2 Clinical Trial Patient Recruitment Services Market Estimates & Forecast, By Therapeutic Areas (USD Million)
  • 6.3 Definitions & Scope
  • 6.4 Clinical Trial Patient Recruitment Services: Market Share Analysis, 2022 & 2030
    • 6.4.1 Pain And Anesthesia
      • 6.4.1.1 Pain And Anesthesia Market, 2018 - 2030 (USD Million)
    • 6.4.2 Oncology
      • 6.4.2.1 Oncology Market, 2018 - 2030 (USD Million)
    • 6.4.3 Central Nervous System
      • 6.4.3.1 Central Nervous System Market, 2018 - 2030 (USD Million)
    • 6.4.4 Cardiovascular
      • 6.4.4.1 Cardiovascular Market, 2018 - 2030 (USD Million)
    • 6.4.5 Respiratory
      • 6.4.5.1 Respiratory Market, 2018 - 2030 (USD Million)
    • 6.4.6 Endocrine
      • 6.4.6.1 Endocrine Market, 2018 - 2030 (USD Million)
    • 6.4.7 Anti-Infective
      • 6.4.7.1 Anti-Infective Market, 2018 - 2030 (USD Million)
    • 6.4.8 Others
      • 6.4.8.1 Others Market, 2018 - 2030 (USD Million)

Chapter 7 Clinical Trial Patient Recruitment Services Market: Age Group Segment Estimates & Trend Analysis

  • 7.1 Clinical Trial Patient Recruitment Services Market By Age Group Segment: Key Takeaways
  • 7.2 Clinical Trial Patient Recruitment Services Market Estimates & Forecast, By Age Group (USD Million)
  • 7.3 Definitions & Scope
  • 7.4 Clinical Trial Patient Recruitment: Market Share Analysis, 2022 & 2030
    • 7.4.1 Child
      • 7.4.1.1 Child Market, 2018 - 2030 (USD Million)
    • 7.4.2 Adults
      • 7.4.2.1 Adults Market, 2018 - 2030 (USD Million)
    • 7.4.3 Older Adults
      • 7.4.3.1 Older Adults Market, 2018 - 2030 (USD Million)

Chapter 8 Regional Estimates & Trend Analysis, 2018 - 2030 (USD Million)

  • 8.1 Regional Outlook
  • 8.2 Regional Market Share Analysis, 2022 & 2030
  • 8.3 Regional Marketplace, Key Takeaways
  • 8.4 Regional Marketplace, Key Takeaways
  • 8.5 North America
    • 8.5.1 Regulatory Framework:
    • 8.5.2 North America Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3 U.S.
      • 8.5.3.1 Key Country Dynamics
      • 8.5.3.2 U.S. Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.5.3.3 Competitive And Market Scenario
    • 8.5.4 Canada
      • 8.5.4.1 Key Country Dynamics
      • 8.5.4.2 Canada Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.5.4.3 Competitive And Market Scenario
  • 8.6 Europe
    • 8.6.1 Regulatory Framework:
      • 8.6.1.1 Europe Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2 Germany
      • 8.6.2.1 Key Country Dynamics
      • 8.6.2.2 Germany Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.2.3 Competitive And Market Scenario
    • 8.6.3 UK
      • 8.6.3.1 Key Country Dynamics
      • 8.6.3.2 UK Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.3.3 Competitive And Market Scenario
    • 8.6.4 France
      • 8.6.4.1 Key Country Dynamics
      • 8.6.4.2 France Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.4.3 Competitive And Market Scenario
    • 8.6.5 Spain
      • 8.6.5.1 Key Country Dynamics
      • 8.6.5.2 Spain Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.5.3 Competitive And Market Scenario
    • 8.6.6 Italy
      • 8.6.6.1 Key Country Dynamics
      • 8.6.6.2 Italy Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.6.3 Competitive And Market Scenario
    • 8.6.7 Denmark
      • 8.6.7.1 Key Country Dynamics
      • 8.6.7.2 Denmark Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.7.3 Competitive And Market Scenario
    • 8.6.8 Sweden
      • 8.6.8.1 Key Country Dynamics
      • 8.6.8.2 Sweden Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.8.3 Competitive And Market Scenario
    • 8.6.9 Norway
      • 8.6.9.1 Key Country Dynamics
      • 8.6.9.2 Norway Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.6.9.3 Competitive And Market Scenario
  • 8.7 Asia Pacific
    • 8.7.1 Regulatory Framework:
      • 8.7.1.1 Asia Pacific Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2 Japan
      • 8.7.2.1 Key Country Dynamics
      • 8.7.2.2 Japan Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.7.2.3 Competitive And Market Scenario
    • 8.7.3 China
      • 8.7.3.1 Key Country Dynamics
      • 8.7.3.2 China Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.7.3.3 Competitive And Market Scenario
    • 8.7.4 India
      • 8.7.4.1 Key Country Dynamics
      • 8.7.4.2 India Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.7.4.3 Competitive And Market Scenario
    • 8.7.5 South Korea
      • 8.7.5.1 Key Country Dynamics
      • 8.7.5.2 South Korea Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.7.5.3 Competitive And Market Scenario
    • 8.7.6 Thailand
      • 8.7.6.1 Key Country Dynamics
      • 8.7.6.2 Thailand Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.7.6.3 Competitive And Market Scenario
    • 8.7.7 Australia
      • 8.7.7.1 Key Country Dynamics
      • 8.7.7.2 Australia Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.7.7.3 Competitive And Market Scenario
  • 8.8 Latin America
    • 8.8.1 Regulatory Framework:
    • 8.8.2 Latin America Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3 Brazil
      • 8.8.3.1 Key Country Dynamics
      • 8.8.3.2 Brazil Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.8.3.3 Competitive And Market Scenario
    • 8.8.4 Mexico
      • 8.8.4.1 Key Country Dynamics
      • 8.8.4.2 Mexico Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.8.4.3 Competitive And Market Scenario
    • 8.8.5 Argentina
      • 8.8.5.1 Key Country Dynamics
      • 8.8.5.2 Argentina Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.8.5.3 Competitive And Market Scenario
  • 8.9 MEA
    • 8.9.1 Regulatory Framework:
    • 8.9.2 MEA Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.9.3 South Africa
      • 8.9.2.1 Key Country Dynamics
      • 8.9.2.2 South Africa Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.9.2.3 Competitive And Market Scenario
    • 8.9.4 Saudi Arabia
      • 8.9.3.1 Key Country Dynamics
      • 8.9.3.2 Saudi Arabia Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.9.3.3 Competitive And Market Scenario
    • 8.9.5 UAE
      • 8.9.4.1 Key Country Dynamics
      • 8.9.4.2 UAE Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.9.4.3 Competitive And Market Scenario
    • 8.9.5 Kuwait
      • 8.9.5.1 Key Country Dynamics
      • 8.9.5.2 Kuwait Clinical Trial Patient Recruitment Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.9.5.3 Competitive And Market Scenario

Chapter 9 Competitive Landscape

  • 9.1 Company Categorization
  • 9.2 Participants Overview
  • 9.3 Financial Performance
  • 9.4 Service Benchmarking
    • 9.4.1 Market Leaders
      • 9.4.1.1 Clinical Trial Patient Recruitment Services Market Share Analysis, 2022
  • 9.5 Strategy Mapping
    • 9.5.1 Service Launches/Upgrades
    • 9.5.2 Mergers/Acquisitions/Joint Ventures
    • 9.5.3 Partnership/ Agreement
    • 9.5.4 Expansion
    • 9.5.5 Others

Chapter 10 Key Takeaways